ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Ms. Aisha has cancer.

Patient Basic Information Patient: Aisha Harris) Country: Chile Disease Diagnosis: Esophageal Cancer Diagnostic Hospital: H0oC Treatment Plan: Targeted Treatment + Immunotherapy Accommodation Day: 33 days Treatment Cost: approximately 1490202 yuan Treatment Effect: Surgery Success Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, guidance and on-site services throughout the treatment process. The MD2 team used a comprehensive set of targeted therapeutic+immunotherapies, with the medical team closely monitoring the patient's indicators and dynamic adjustment programs during the treatment process. After 33 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the hospital standard.

The patient's final surgical results were successful. When the patient left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to follow the recovery through the remote follow-up system. 'Ladies Aisha, experts have criticized this case as a typical case of cross-border suspected seriousness clinical cases.

A multi-disciplinary collaborative mechanism for the development of targeted treatment+immunotherapy for esophageal cancer demonstrates the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and a summary of how international medical services are regulated.

智利,食管癌,上海交通大学医学院附属瑞金医院,国际医疗,来华就医,中国医疗